Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post trauma...Show More
peer of
competitor of
Metrics
marketSTOCKS
msh_idCOM:BRAINSWAY
localeil
websitehttps://www.brainsway.com/
ipo_date2007-03-28
primary_stock_msh_idTLV:BWAY
source_refd206c11e-7255-4a39-845b-4f4526900bc6
products_or_servicesDeep Transcranial Magnetic Stimulation (Deep TMS) for the treatment of conditions including major depressive disorder, anxious depression, late-life depression, obsessive-compulsive disorder, smoking addiction, and various neurological disorders.
Israel